Immunoengineering @ PME 10th Year Anniversary

As part of the Pritzker School of Molecular Engineering (PME) 10th Year Anniversary events, the immunoengineering theme is featured in a breakout session from 9am - 12pm of the Alumni & Industry Day portion of the event. The presentations and discussions will review achievements by PME immunoengineers over the last ten years, and an outlook on the future of the field and what different thought leaders are doing to position themselves and their organizations at the forefront of the rapid developments in the biomedical landscape.

Event Location (for in-person attendees):
David Rubenstein Forum, Room 701
1201 E 60th St
Chicago, IL 60637

Virtual Event Link: Register here to receive the details - https://pme10thanniversary.com/user/login

Schedule for the event, which will be delivered in hybrid, will be:

9:00-9:10 - Opening Remarks
Shann Yu, PhD (Scientific Director of the Immunoengineering Center)

---

9:15-10:00 - Faculty Innovations

Prof. Cathryn Nagler, PhD (Bunning Family Professor in the Department of Pathology, Pritzker School of Molecular Engineering, and the College)
"Developing microbiome modulating therapeutics"

Prof. Samantha Riesenfeld, PhD (Assistant Professor of Molecular Engineering and Genetic Medicine)
"Machine learning from genomic data to predict cellular transformations"

Prof. Savas Tay, PhD (Professor of Molecular Engineering)
"Getting to know your cells deeper: Empowering and enriching the information and data content gleaned from single cells in real-time"

---

10:00-10:15 - Break

---

10:15-11:10 - Biomedical Innovation across Academia & Industry:
Moderator: Shann Yu, PhD (Scientific Director of the Immunoengineering Center)

Panelists:
- Jay Cui, PhD’09, MBA’15 (Principal at Abingworth Management)
- Prof. Jeffrey Hubbell, PhD (Eugene Bell Professor in Tissue Engineering, Vice Dean, and Executive Officer of the PME)
- Jasmina Marjanovic, PhD’10 (Director at Abbvie Ventures)
- Paul Song, MD, BA'87 (Co-founder and CEO of Fuse Therapeutics & Virafuse Biotherapeutics)

---

11:15-12:00 - Grand Challenges Keynote: "Manipulating Tolerance in Autoimmunity and Organ Transplantation"
Prof. Jeffrey Bluestone, PhD (President and Chief Executive Officer of Sonoma Biotherapeutics and the A.W. and Mary Margaret Clausen Distinguished Professor at the Diabetes Center of The University of California, San Francisco)<br /><br /><strong>Date:</strong> September 17, 2021<br /><strong>Time:</strong> 9:00 AM - 12:00 PM<br /><br /><strong>See:</strong> <a href="https://anniversary.pme.uchicago.edu/immunoengineering-morning-program/… />